Bolt Biotherapeutics, Inc.
For the period ended May 27, 2025. Filed Apr 25, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 27, 2025 · Filed Apr 25, 2025
Contents
ADDITIONAL INFORMATION
Our Form 10-K has been posted on our corporate website at https://investors.boltbio.com/financial-information/sec-filings and atwww.proxydocs.com/BOLT. Stockholders receiving a printed copy of this Proxy Statement have also received a copy of our Form 10-K. We will provide, without charge, a copy of our Form 10-K for the year ended December 31, 2024 (including the financial statements but excluding the exhibits thereto) upon the written request of any stockholder or beneficial owner of our common stock. Requests should be directed to our Secretary the following address:
Bolt Biotherapeutics, Inc.
900 Chesapeake Drive
Redwood City, CA 94063
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.